Summit Securities Group’s Teladoc Health TDOC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q1
Sell
-150
Closed -$3M 765
2020
Q4
$3M Buy
+150
New +$30.5K 0.25% 103

Other funds holding TDOC

Summit Securities Group's TDOC Position: Q1 2021 in Review

Summit Securities Group sold out of Teladoc Health (TDOC) in Q1 2021, closing a stake of 1,300 shares — an estimated $260K sold.

Summit Securities Group first reported a position in TDOC in Q4 2019 and held it in 3 quarters. The position peaked at $1.55M in Q1 2020. 889 funds tracked by Wall St. Rank hold TDOC as of Q1 2021.

  • Summit Securities Group reported no remaining Teladoc Health position as of Q1 2021 after selling out during the quarter.
  • Summit Securities Group sold 1,300 Teladoc Health shares in Q1 2021, an estimated $260K.
  • Summit Securities Group first reported a position in Teladoc Health in Q4 2019 and held it in 3 quarters.
  • Summit Securities Group's Teladoc Health position peaked at $1.55M in Q1 2020.
  • 889 funds tracked by Wall St. Rank held Teladoc Health as of Q1 2021.

Based on Summit Securities Group's 13F filing for Q1 2021, filed 14 Apr 2021.